London, UK and Paris, France 03 September 2020 — Sanofi and GSK announce today the start of the Phase 1/2
Continue reading »
Home »
Alnylam Announces Plan to Initiate Rolling Submission of a New Drug Application and Pursue Full Approval for Givosiran
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 15, 2018– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that in consultation
Continue reading »
Amplification of key cellular organizer may initiate cancer, study suggests
Cells begin to accumulate centrosomes—organelles that play a vital role during cell division—before they transform into cancer cells, according to
Continue reading »